Related Experiment Video
Updated: Jan 17, 2026

08:56
Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
Published on: October 7, 2021
3.3K
Complement profiling of sural nerves in chronic-inflammatory demyelinating polyneuropathy.
Frauke Stascheit1,2, Andreas Roos3,4,5, Christina B Schroeter3
1Charité-Universitätsmedizin Berlin, Department of Neurology With Experimental Neurology, Corporate Member of Freie Universität Berlin and Humboldt Universität Zu Berlin, Charitéplatz 1, 10117, Berlin, Germany. frauke.stascheit@charite.de.
Acta Neuropathologica
|September 19, 2025
Summary
Complement complex C5b-9 deposition is prevalent in chronic-inflammatory demyelinating polyneuropathy (CIDP) nerve biopsies, correlating with disease severity. This finding supports complement-targeted therapies for CIDP patients.
Area of Science:
- Neurology
- Immunology
- Pathology
Background:
- Chronic-inflammatory demyelinating polyneuropathy (CIDP) is a rare, disabling immune-mediated disorder.
- The role of the complement system in CIDP pathogenesis is not well understood.
- Understanding complement's role is crucial given the development of complement-targeted treatments.
Purpose of the Study:
- To investigate the involvement of the complement system in the sural nerve pathology of CIDP patients.
- To correlate complement deposition with clinical disease severity and immune cell infiltration.
Main Methods:
- Sural nerve biopsies from 55 CIDP patients, 2 non-diseased controls (NDCs), and 8 patients with hereditary neuropathy (HN) or idiopathic axonal neuropathy (IPN) were analyzed.
- Histopathology, gene expression, and proteomics were employed to assess complement deposition and related molecular changes.
- Immunohistochemistry was used to quantify CD8+ T cells and CD68+ macrophages.
Main Results:
- Prominent deposition of terminal complement complex C5b-9 was observed in endoneurial capillaries of 94% of CIDP patients.
- Significant complement deposition correlated with a progressive disease course and infiltration of CD8+ T cells and CD68+ macrophages.
- The extent of immune cell infiltration correlated with clinical disease severity (INCAT score, p < 0.001).
Conclusions:
- This study demonstrates significant complement involvement in CIDP nerve pathology, supporting the concept of complement-mediated demyelination.
- The findings suggest that targeting the complement system could be a promising therapeutic strategy for a subset of CIDP patients.
- Further research is needed to elucidate the functional role of complement in CIDP progression and optimize patient management.
Keywords:
Chronic-inflammatory demyelinating polyneuropathyComplement profilesGene expressionProteomicsSural nerve
